Source comparison
Melanotan-1 Men Over 40: Research Protocol Comparison
Research protocols examining Melanotan-1 in male subjects over 40 vary significantly in dosing schedules, endpoint measurements, and control group design. The table below compares common experimental approaches used in melanocortin receptor studies across age-
This comparison does not assign a generated winner or score.
- Research protocols examining Melanotan-1 in male subjects over 40 vary significantly in dosing schedules, endpoint measurements, and control group design. The table below compares common experimental approaches used in melanocortin receptor studies across age-stratified populations.
- Single-dose receptor binding
- 0.1–1.0 mg/kg
- 24–72 hours
- MC1R occupancy via radioligand assay
- Baseline receptor density 15–20% lower in subjects >40
- Essential for establishing dose-response curves; requires age-matched controls
- Multi-week melanogenesis induction
- 0.016–0.25 mg/kg daily
- 4–12 weeks
- Melanin index via reflectance spectrophotometry
- Baseline melanin 10–18% lower in subjects >40
- Gold standard for photoprotection research; baseline correction critical
- UV tolerance (MED) study
- 0.016 mg/kg daily
- 2–4 weeks
- Minimal erythema dose measurement
- Cumulative photoaging lowers baseline MED independent of peptide
- Functional endpoint; difficult to isolate peptide effect from intrinsic aging
- Receptor expression analysis
- In vitro (tissue samples)
- N/A. Ex vivo
- MC1R mRNA or protein quantification
- Age-related decline in receptor transcription
- Mechanistic depth; directly measures the biological variable most affected by age